
Addison D. Ault
Examiner (ID: 4133, Phone: (571)270-7028 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636 |
| Total Applications | 403 |
| Issued Applications | 199 |
| Pending Applications | 3 |
| Abandoned Applications | 201 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15469029
[patent_doc_number] => 10550379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => Degron fusion constructs and methods for controlling protein production
[patent_app_type] => utility
[patent_app_number] => 15/737712
[patent_app_country] => US
[patent_app_date] => 2016-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 42
[patent_no_of_words] => 27738
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737712
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/737712 | Degron fusion constructs and methods for controlling protein production | Jun 27, 2016 | Issued |
Array
(
[id] => 13247959
[patent_doc_number] => 10136649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-27
[patent_title] => Methods for screening bacteria, archaea, algae, and yeast using CRISPR nucleic acids
[patent_app_type] => utility
[patent_app_number] => 15/167727
[patent_app_country] => US
[patent_app_date] => 2016-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 31
[patent_no_of_words] => 33024
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15167727
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/167727 | Methods for screening bacteria, archaea, algae, and yeast using CRISPR nucleic acids | May 26, 2016 | Issued |
Array
(
[id] => 14246159
[patent_doc_number] => 10273271
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => Methods of transcription activator like effector assembly
[patent_app_type] => utility
[patent_app_number] => 15/156574
[patent_app_country] => US
[patent_app_date] => 2016-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 38
[patent_no_of_words] => 32189
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 281
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15156574
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/156574 | Methods of transcription activator like effector assembly | May 16, 2016 | Issued |
Array
(
[id] => 11290812
[patent_doc_number] => 20160340744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'MIR-211 EXPRESSION AND RELATED PATHWAYS IN HUMAN MELANOMA'
[patent_app_type] => utility
[patent_app_number] => 15/130856
[patent_app_country] => US
[patent_app_date] => 2016-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 22216
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15130856
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/130856 | miR-211 expression and related pathways in human melanoma | Apr 14, 2016 | Issued |
Array
(
[id] => 11011030
[patent_doc_number] => 20160207983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'Methods, Cells & Organisms'
[patent_app_type] => utility
[patent_app_number] => 15/094624
[patent_app_country] => US
[patent_app_date] => 2016-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 23043
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15094624
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/094624 | Methods, Cells & Organisms | Apr 7, 2016 | Abandoned |
Array
(
[id] => 11109004
[patent_doc_number] => 20160305970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'CELL LINES AND METHODS FOR MAKING AND USING THEM'
[patent_app_type] => utility
[patent_app_number] => 15/077747
[patent_app_country] => US
[patent_app_date] => 2016-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54988
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15077747
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/077747 | CELL LINES AND METHODS FOR MAKING AND USING THEM | Mar 21, 2016 | Abandoned |
Array
(
[id] => 12260865
[patent_doc_number] => 20180080061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'BIOSYNTHETIC LABELING AND SEPARATION OF RNA'
[patent_app_type] => utility
[patent_app_number] => 15/557391
[patent_app_country] => US
[patent_app_date] => 2016-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7686
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15557391
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/557391 | BIOSYNTHETIC LABELING AND SEPARATION OF RNA | Mar 17, 2016 | Abandoned |
Array
(
[id] => 12009936
[patent_doc_number] => 09803243
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-31
[patent_title] => 'Biomarkers for diagnosis of stroke and its causes'
[patent_app_type] => utility
[patent_app_number] => 15/068600
[patent_app_country] => US
[patent_app_date] => 2016-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 42886
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 223
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15068600
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/068600 | Biomarkers for diagnosis of stroke and its causes | Mar 12, 2016 | Issued |
Array
(
[id] => 10980396
[patent_doc_number] => 20160177340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'Methods, Cells & Organisms'
[patent_app_type] => utility
[patent_app_number] => 15/062890
[patent_app_country] => US
[patent_app_date] => 2016-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 23038
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15062890
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/062890 | Methods, Cells & Organisms | Mar 6, 2016 | Abandoned |
Array
(
[id] => 13970779
[patent_doc_number] => 10214732
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Lysin agent and method of use for diagnostic testing
[patent_app_type] => utility
[patent_app_number] => 15/047319
[patent_app_country] => US
[patent_app_date] => 2016-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15367
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15047319
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/047319 | Lysin agent and method of use for diagnostic testing | Feb 17, 2016 | Issued |
Array
(
[id] => 10806832
[patent_doc_number] => 20160152990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Polypeptide Containing DNA-Binding Domain'
[patent_app_type] => utility
[patent_app_number] => 15/019630
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11330
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019630
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019630 | Polypeptide containing DNA-binding domain | Feb 8, 2016 | Issued |
Array
(
[id] => 11034377
[patent_doc_number] => 20160231332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'Methods and Devices for Detecting Kidney Damage'
[patent_app_type] => utility
[patent_app_number] => 15/014993
[patent_app_country] => US
[patent_app_date] => 2016-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 19456
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15014993
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/014993 | Methods and Devices for Detecting Kidney Damage | Feb 2, 2016 | Abandoned |
Array
(
[id] => 11018322
[patent_doc_number] => 20160215275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'Chemically Ligated RNAs for CRISPR/Cas9-lgRNA Complexes as Antiviral Therapeutic Agents'
[patent_app_type] => utility
[patent_app_number] => 15/006131
[patent_app_country] => US
[patent_app_date] => 2016-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7314
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15006131
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/006131 | Chemically ligated RNAs for CRISPR/Cas9-lgRNA complexes as antiviral therapeutic agents | Jan 25, 2016 | Issued |
Array
(
[id] => 11837887
[patent_doc_number] => 20170219606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'CELL LINES EXPRESSING NaV AND METHODS OF USING THEM'
[patent_app_type] => utility
[patent_app_number] => 15/000974
[patent_app_country] => US
[patent_app_date] => 2016-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19396
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15000974
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/000974 | CELL LINES EXPRESSING NaV AND METHODS OF USING THEM | Jan 18, 2016 | Abandoned |
Array
(
[id] => 11046208
[patent_doc_number] => 20160243167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR MESENCHYMAL/STROMAL STEM CELL REJUVENATION AND TISSUE REPAIR BY ENHANCED CO-EXPRESSION OF TELOMERASE AND MYOCARDIN'
[patent_app_type] => utility
[patent_app_number] => 14/995061
[patent_app_country] => US
[patent_app_date] => 2016-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12865
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14995061
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/995061 | COMPOSITIONS AND METHODS FOR MESENCHYMAL/STROMAL STEM CELL REJUVENATION AND TISSUE REPAIR BY ENHANCED CO-EXPRESSION OF TELOMERASE AND MYOCARDIN | Jan 12, 2016 | Abandoned |
Array
(
[id] => 11243839
[patent_doc_number] => 09469875
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-18
[patent_title] => 'Methods for detection of depressive disorders'
[patent_app_type] => utility
[patent_app_number] => 14/994802
[patent_app_country] => US
[patent_app_date] => 2016-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9371
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14994802
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/994802 | Methods for detection of depressive disorders | Jan 12, 2016 | Issued |
Array
(
[id] => 10799487
[patent_doc_number] => 20160145644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'TARGETED GENOMIC MODIFICATION WITH PARTIALLY SINGLE-STRANDED DONOR MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 14/990300
[patent_app_country] => US
[patent_app_date] => 2016-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 27451
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14990300
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/990300 | Targeted genomic modification with partially single-stranded donor molecules | Jan 6, 2016 | Issued |
Array
(
[id] => 14045937
[patent_doc_number] => 20190079075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => PHARMECEUTICAL COMPOSITION FOR LUNG CANCER TREATMENT AND METHODS FOR PROVIDING INFORMATION AND SCREENING
[patent_app_type] => utility
[patent_app_number] => 15/743092
[patent_app_country] => US
[patent_app_date] => 2016-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15743092
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/743092 | PHARMECEUTICAL COMPOSITION FOR LUNG CANCER TREATMENT AND METHODS FOR PROVIDING INFORMATION AND SCREENING | Jan 5, 2016 | Abandoned |
Array
(
[id] => 13154405
[patent_doc_number] => 10093917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Compositions, methods and kits for real-time nucleic acid analysis in live cells
[patent_app_type] => utility
[patent_app_number] => 14/985826
[patent_app_country] => US
[patent_app_date] => 2015-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 36
[patent_no_of_words] => 33574
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14985826
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/985826 | Compositions, methods and kits for real-time nucleic acid analysis in live cells | Dec 30, 2015 | Issued |
Array
(
[id] => 11528837
[patent_doc_number] => 20170088813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'Biologically active C-terminal arginine-containing peptides'
[patent_app_type] => utility
[patent_app_number] => 14/757925
[patent_app_country] => US
[patent_app_date] => 2015-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6963
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14757925
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/757925 | Biologically active C-terminal arginine-containing peptides | Dec 23, 2015 | Abandoned |